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The maternal-to-zygotic transition (MZT) is a process that occurs in animal embryos at the
earliest developmental stages, during which maternally deposited mRNAs and other
molecules are degraded and replaced by products of the zygotic genome. The zygotic
genome is not activated immediately upon fertilization, and in the pre-MZT embryo
post-transcriptional control by RNA-binding proteins (RBPs) orchestrates the first steps of
development. To identify relevant Drosophila RBPs organism-wide, we refined the RNA
interactome capture method for comparative analysis of the pre- and post-MZTembryos. We
determine 523 proteins as high-confidence RBPs, half of which were not previously reported
to bind RNA. Comparison of the RNA interactomes of pre- and post-MZT embryos reveals
high dynamicity of the RNA-bound proteome during early development, and suggests active
regulation of RNA binding of some RBPs. This resource provides unprecedented insight into
the system of RBPs that govern the earliest steps of Drosophila development.
DOI: 10.1038/ncomms12128 OPEN
1 European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany. 2 German Cancer Research Center, Im Neuenheimer Feld 580,
69120 Heidelberg, Germany. 3 Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, England. Correspondence and requests
for materials should be addressed to A.E. (email: ephrussi@embl.de).
NATURE COMMUNICATIONS | 7:12128 | DOI: 10.1038/ncomms12128 | www.nature.com/naturecommunications 1
T
he maternal-to-zygotic transition (MZT) occurs in animal
embryos during the first stages of development. In this
process maternally deposited molecules are degraded
and gradually replaced by products of the zygotic genome1–3.
However, zygotic genome activation does not occur immediately
upon fertilization: for example, in Drosophila, the zygote’s DNA
remains mostly transcriptionally silent for hours after pronuclear
fusion, and early development is controlled by maternal
messenger RNAs (mRNAs) and the RNA-binding proteins
(RBPs) that regulate them. RBPs constitute a heterogeneous
class of proteins that control all aspects of an mRNA’s lifecycle.
A dynamic set of RBPs associates with and accompanies nascent
transcripts throughout maturation, localization, translation and
decay. Previous attempts to create a census of RBPs of a cell
relied on homology searches and in vitro approaches. While
computational analyses contributed to annotate the compendium
of RBPs harbouring classical RNA-binding domains, their
capacity to discover unorthodox RBPs was limited4. In vitro
protein–RNA screens reported RNA binding not only of
canonical RBPs, but also of proteins previously unrelated to
RNA biology5,6 However, the promiscuity of protein–RNA
interactions under in vitro conditions calls for validation of
these unconventional RBPs in a physiological environment.
Recently, a proteome-wide method for RBP identification was
developed and applied successfully to different cell lines7–9,
budding yeast10,11 and the nematode C. elegans11. This method,
named ‘RNA interactome capture’12 solves some of the
limitations described above, by isolation and identification of
RBPs in living cells. The method involves ultraviolet cross-linking
of proteins to nucleic acids in live cells, followed by the capture of
polyadenylated (poly(A)þ ) RNAs via hybridization to oligo(dT)
beads under denaturing conditions. The proteins directly bound
to poly(A)þ RNAs are then identified and quantified by mass
spectrometry (MS).
We have further developed RNA interactome capture to enable
identification of the RBPs functioning in a living multicellular
organism, the Drosophila embryo. Beyond providing a compre-
hensive compendium of Drosophila melanogaster RBPs, we have
applied this method to embryos at two different developmental
stages employing a multiplexed proteomic approach, generating,
to our knowledge, the first dynamic RNA interactome until now.
Comparison of samples prepared from early and late embryos
reveals that the RNA interactome undergoes important changes
during development. This plasticity of the RNA-bound proteome
can be explained either by changes in overall protein abundance
or modulation of the RNA-binding activity of RBPs. Our analysis
provides new insight into the molecular features of early
development by highlighting proteins that may link development
to RNA metabolism.
Results
Capture of RBPs in the Drosophila embryo. To explore the
landscape of RBPs in the early Drosophila embryo we further
developed the RNA interactome capture method established by
Castello et al.8,12, that was initially optimized for cell lines. This
method employs in vivo cross-linking of protein–RNA complexes
and subsequent capture on oligo(dT) magnetic beads. Irradiation
with 254 nm ultraviolet light activates the nucleotide bases that
then rapidly form stable covalent bonds with some amino acid
residues, preferentially nucleophilic and aromatic, placed at
‘zero distance’13, and does not induce detectable formation of
protein–protein cross-links. Although 254 nm ultraviolet light
does not reach the deepest volume of the embryo14, it was the
only agent suitable for reproducible and efficient cross-linking of
RNA to protein in vivo available to us. Capture of poly(A)þ
RNA by hybridization with oligo(dT) probes is compatible with
the use of high salt concentrations and ionic detergents for
efficient removal of non-covalently bound proteins. The resulting
samples are compatible with tandem mass tag (TMT) labelling
for multiplexed quantitative proteomics using Orbitrap MS
combined with rigorous statistical methods to catalogue
proteins as high-confidence RBPs (Fig. 1a).
After testing a spectrum of cross-linking conditions, we
selected 1 J cm 2 of 254 nm ultraviolet light as the lowest
dose of ultraviolet light resulting in sufficient protein–RNA
cross-linking (Supplementary Fig. 1a–f, discussed in the
Supplementary Note 1) without causing detectable RNA damage
(Fig. 1b). Also, ultraviolet doses up to 1.5 J cm 2 did not result in
tubulin contamination. Furthermore, quantitative analysis by
Agilent Bioanalyzer 2100 (Fig. 1b) showed that the captured
polyadenylated (polyAþ ) RNA was depleted of highly abundant
non-coding RNAs: transfer RNAs were undetectable and
ribosomal RNA (rRNA) amounts reduced to o10% of the
captured RNA, when compared to whole-embryo total RNA
(Fig. 1b). Reverse transcription quantitative polymerase chain
reaction (RT-qPCR) confirmed a multifold enrichment of both
the abundant gapdh mRNA and the low abundance ts mRNA
over 18S rRNA (Fig. 1c).
Gel electrophoresis combined with silver staining revealed that
oligo(dT)-bound fractions recovered from ultraviolet-irradiated,
cross-linked (CL) embryos contained a complex protein mixture
distinct from the total lysate, whereas the non-cross-linked
(noCL) controls were essentially devoid of proteins (Fig. 1d).
Specific purification of well-known RBPs was confirmed by
western blotting (Fig. 1e). Vasa, eIF4E, Pabp2, PABPC and Hrp48
were strongly enriched in eluates only when ultraviolet light was
applied to the embryos, while typical contaminants such as
histone H3 and RNP components that do not directly bind RNA
such as exon junction complex component Y14 (ref. 15) and
kinesin16 were depleted in our samples. However, in some cases
we could detect a faint a-tubulin band in ultraviolet-irradiated
samples (red asterisk, Supplementary Fig. 1h). We further
improved the stringency of lysis by increasing DTT
concentration to 12.5mM and incubating lysates at 60 C for
15min before oligo(dT) bead addition, which resulted in
complete removal of a-tubulin from ultraviolet-irradiated
samples. This additional treatment did not induce detectable
protein (Supplementary Fig. 1i–p) or RNA (Supplementary
Fig. 1g) degradation, suggesting that high temperature enhances
protein denaturation and improves removal of non-covalent RNA
binders.
Determination of the Drosophila RNA interactome. To obtain a
comprehensive view of RBPs in Drosophila, we applied RNA
interactome capture to early, pre-MZT (0–1 h post-fertilization)
and late (4.5–5.5 h), post-MZT embryos (Fig. 1f). By visual
inspection using DAPI-staining we confirmed that more than
95% of embryos were at the expected stage (Supplementary
Fig. 1q–s). For total interactome determination we pooled early
and late samples to obtain three biological replicates—three CL
and three noCL, control samples—that were analyzed in parallel
using TMT MS with six different isobaric labels (TMT MS3
(ref. 17), Methods and Supplementary Note 2). This resulted in
identification of 2,336 peptides, 2,200 of which could be mapped
to a unique protein model, leading to 978 proteins identified.
Protein intensity ratios in CL over noCL samples were calculated
for 187 proteins, 65 of which were significantly enriched (1% false
discovery rate (FDR), red dots Fig. 1g; Supplementary Fig. 1t,u).
Quantification of the remaining proteins was impossible by the
mentioned method due to extremely low abundance of these
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proteins in the control (noCL) samples, which resulted in the
absence of intensity values required to calculate protein abun-
dance ratios.
To overcome the technical difficulty of missing intensity values
in the noCL samples, we performed a semi-quantitative analysis
taking into consideration the number of peptide occurrences in
ultraviolet-irradiated and non-irradiated samples for each protein
across the three biological replicates (Supplementary Fig. 1v). The
number of peptide occurrences in the negative controls and
ultraviolet-irradiated samples was used to compute the incidence
of false-positives and to estimate the FDR. By this analysis only
peptides occurring predominantly and reliably (FDR 1%) in CL
samples over the noCL controls were considered positive hits
(Supplementary Fig. 1v). In total 523 proteins qualified as
high-confidence RBPs by direct comparison of protein ratios or
semi-quantitative analysis (Fig. 1h). Hereafter, we refer to this set
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Figure 1 | Identification of the Drosophila RNA interactome. (a) Direct RNA binders are CL to mRNAs in living Drosophila embryos, which are
subsequently lysed under denaturing conditions. mRNA-protein complexes are purified by hybridization with oligo(dT) magnetic beads and a series of
stringent washes. Proteins are released by RNase treatment and are ready for MS analysis. (b) Analysis of total and oligo(dT) by Bioanalyzer 2100 captured
RNA shows depletion of abundant ncRNAs. (c) Multifold enrichment of polyadenylated gapdh and ts mRNAs in oligo(dT) bound fractions confirmed by
RT-qPCR. On the x axis are indicated the samples in which the amounts of the different RNAs were measured: Input noCL, input CL, eluate noCL, eluate CL.
The y axis represents the fold enrichment of RNA amounts in the different samples. RNA amounts in noCL input were defined as 1. Error bars: s.d. See
Supplementary Table 1 for information on oligonucleotides used for the analysis. (d) Protein profiles of total embryo and RNA-bound fractions. (e) Analysis
of total embryo lysates and oligo(dT) bound fractions by western blotting with antibodies against Vasa, eIF4E, Pabp2, PABPC, Hrp48, tubulin, Y14 and H3.
Lysis at 60 C and 12.5mM DTTensures that tubulin background is removed. See Supplementary Table 2 for antibody information. (f) Replicated samples
prepared from pre- (0–1 h) and post-MZT (4.5–5.5 h) embryos are mixed to generate three aggregate CL and noCL (control) samples. Proteins are partially
digested, TMT labelled and quantified by MS. (g) Scatter plot showing protein abundance ratios CL/noCL in two replicates. Red dots represent proteins
significantly enriched in CL samples. (h) Venn diagram comparing numbers of detected and significantly enriched proteins.
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of proteins as the Drosophila mRNA interactome (Supplementary
Data 1).
Discovery of hundreds of novel Drosophila RBPs. As expected,
gene ontology (GO) term enrichment analysis of the RNA
interactome, as compared to the total lysate, revealed enrichment
of biological processes in which RNA has a key role, such as
translation and RNP structure organization (Supplementary
Fig. 2a). We counted the RNA interactome proteins annotated
by the GO term ‘RNA binding’ as well as other RNA-related GO
terms (any GO term that contains ‘RNA’, for example, ‘RNA
splicing’) (Fig. 2a). RNA interactome capture ‘re-discovered’
136 proteins (of 523; 26%) previously annotated as binding RNA,
while in the total proteome the number of such proteins was 293
(of 3,126 proteins identified in the total lysate, not including
interactome proteins; 9%; for the analysis of total proteome see
below). A total of 134 (out of 523; 26%) RNA interactome
proteins were not annotated by the GO term ‘RNA binding’ but
were nevertheless annotated with other RNA-related GO terms
(Fig. 2a). The number of proteins falling into this category in the
total embryo proteome was 639 (of 3,126; 20%). Interestingly,
the remaining 253 RNA interactome proteins could not be linked
to RNA biology based on current GO annotation. Although 17 of
these do harbour a well-established RNA-binding domain (RBD)
according to the Pfam database, the other 236 lack known RBDs
and are hereafter referred to as novel or newly discovered RBPs
(Fig. 2b).
A parallel study reports the RNA interactome of early
Drosophila embryos18. The total number of high-confidence
RBPs identified by Wessels et al. (476) is comparable to the
number we identified and also includes many proteins not
previously shown to bind RNA (99).
Low complexity and disordered regions in Drosophila RBPs.
The RNA interactome comprises 47 distinct types of known
RBDs, as expected of a catalogue of bona fide RBPs. Compared to
the total embryo lysate, our dataset is significantly enriched
in canonical RBDs such as RNA recognition motif (RRM),
ribosomal and K-homology (KH) domains (Supplementary
Fig. 2b,c). Note that most previously known RBDs, such as the
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Figure 2 | Composition of the Drosophila mRNA interactome and its links to development. (a) Blue bars: numbers of proteins annotated with GO term
‘RNA binding’ and other RNA-related GO terms. Green bars: numbers of proteins containing and not containing domains annotated as RNA-binding in
the Pfam database. Dark blue: GO term ‘RNA binding’; medium blue: RNA-related GO terms; light blue: GO annotation unrelated to RNA; dark green:
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interactome. Two-sample Kolmogorov–Smirnov test P values are listed in the Supplementary Note 3. (d) Five most frequent repetitive sequence patterns in
the RNA interactome. (e) Venn diagram showing numbers of proteins belonging to the human (yellow), mouse (pink) and fly (green) interactomes. Of 266
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compared to RNA-related GO terms (blue bars). Green bars: numbers of proteins with Pfam-annotated known RBDs. (g) Fractions of proteins with
embryonic, lethal and sterile phenotypes in the RNA interactome (blue) and the proteome (red). Fischer test P values resulting from comparison of the
interactome to the proteome: lethal—0.00346; embryonic—0.03483; sterile—0.0001754.
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La domain, dsRBP (DSRM) and zinc-finger domains, were
overrepresented in the RNA interactome compared to the whole
embryo lysate but their enrichment did not qualify as statistically
significant due to the small number of proteins containing such
domains in the Drosophila embryo proteome (Supplementary
Fig. 2b).
Of the 523 Drosophila RNA interactome proteins, 70 (of 287)
previously known and 37 (of 236) newly discovered RBPs contain
repetitive motifs in intrinsically disordered regions, which are
protein segments lacking a stable three-dimensional structure,
typically of low amino acid complexity (Fig. 2c,d; Supplementary
Fig. 2d; Supplementary Note 3). Such regions were previously
reported to be overrepresented among RBPs in mammals8,9.
However, in contrast to mammals, the most prevalent repetitive
regions in Drosophila RNA interactome are based on the neutral
amino acids glycine, glutamine and asparagine (Fig. 2d;
Supplementary Fig. 2d).
Although the whole RNA interactome is enriched in
disordered, low complexity and repetitive regions compared to
the total proteome, the novel proteins are on average less
disordered than previously known RBPs (Fig. 2d). A similar
pattern was observed for the RBPs identified in mouse embryonic
stem cells9, while novel human RBPs were, on the contrary, more
disordered than those previously known8. These observations
might reflect differences in RBP functions, the mechanisms that
drove evolution of RBPs in these species, or annotation biases.
Although our observations call for further investigation, we find it
probable that the difference in disorder of novel and previously
known Drosophila RBPs is not caused by experimental bias, as
other parameters such as average length, isoelectric point and
hydrophobicity are similar for these two groups (Supplementary
Fig. 2e–g). In addition, amino acid composition of the novel and
previously known RBPs is similar, and the significant enrichment
of positively charged residues observed in both groups is
characteristic of RBPs (Supplementary Fig. 2h,i).
Drosophila and other eukaryotic interactomes compared. We
compared the Drosophila RNA interactome to the compendium
of human (sum of HeLa8, HEK293 (ref. 7) and HuH7 (ref. 10)
data sets), mouse9, worm11 and yeast (sum of refs 11 and 10)
RNA interactomes. Supplementary Fig. 2j shows a Venn diagram
comparing all five available RNA interactomes, and Fig. 2e a
Venn diagram of mouse, human and fly data. A total of 336 out of
523 proteins were detected as RBPs in at least one of the 4 species
and 105 proteins in at least 3 species (Fig. 2e; Supplementary
Data 2). Comparison to the GO term ‘RNA binding’ and other
RNA-related GO-terms (Fig. 2f, blue bars) revealed that these
proteins are enriched in core elements of the splicing and
translation machineries: for example, 32 structural ribosomal
proteins constitute 22% of the common fly, human and mouse
RBPs, while this class constitutes only 6% of fly-specific RBPs
(12 of 191). In agreement with this observation, proteins
harbouring classical RBDs were highly prevalent across the
proteins shared by all four RNA interactomes—(86%, 31 of 36)
while the number of proteins harbouring known RBDs is lower
among fly embryo-specific RBPs (14%, 27 of 191).
Novel Drosophila RBPs are involved in development. We used
published information to evaluate possible links between RBPs we
identified and development. In our RNA interactome capture
experiment, half the sample was generated from 4.5 to 5.5 h
embryos (Fig. 1b) in which the first cell types differentiate19,
including neuroblasts20. We used mRNA localization data21 to
identify mRNAs encoding RBPs expressed in neuroblasts and that
might be involved in neuroblast specification and nervous system
development. Among the 24 mRNAs localized to neuroblasts,
three encode novel RBPs, including HmgD, Dpa and Mcm2.
Mcm2 and 42 other novel RBPs discovered in this study were also
identified in an RNAi screen22 as having roles in neuroblast
development.
Next, we took advantage of the wealth of phenotypic data
for D. melanogaster in Flybase23 and extracted phenotypic
descriptions for alleles of genes encoding RNA interactome
proteins. The numbers of proteins for which at least one allele is
associated with an embryonic, lethal or sterile phenotype are
shown in Fig. 2g: 150 (29%) are associated with embryonic
phenotypes, 236 (45%)—with lethal phenotype and 72 (14%)—
with sterility. Note that protein sets falling into each phenotypic
class often overlap: for example, among 150 proteins with
embryonic phenotypes 144 were also lethal (Supplementary
Fig. 2k). We also calculated fractions of proteins with which
phenotypes are associated in the RNA interactome and the total
proteome and found that for each of the three considered
phenotypic classes this fraction was higher in the interactome
(Fig. 2g). We classified proteins in each of the three phenotypic
classes according to their molecular function using GO
annotation. Among the proteins with lethal phenotypes, 15 had
no assigned molecular function (Supplementary Fig. 2l).
Interestingly, based on their mutant phenotypes, 9 of these are
implicated in nervous system development: Fax, CSN1b, Nedd8,
Ars2, Nopp140, Nop56, CG6066, Tap42, Patr-1.
Discovery of several metabolic enzymes as RBPs in Drosophila
is consistent with findings of other interactome capture
studies8,10,11 and is noteworthy, as energy production was
shown to be an important factor in developmental processes in
some organisms24,25, and its regulation might have a role in the
MZT in Drosophila26 As for the mammalian and yeast
interactomes10,11, our Drosophila interactome contains a
substantial number (47) of proteins listed as enzymes (http://
enzyme.expasy.org/). Whereas in yeast all steps of the glycolytic
pathway can be catalyzed by enzymes identified as RNA binders,
some of them binding mRNAs encoding glycolytic enzymes10,11,
in Drosophila only two glycolytic enzymes—phosphofructokinase
and phosphoglyceromutase—are found in the RNA interactome
(Supplementary Data 3). Further experiments on individual
proteins will elucidate the role(s) of RNA binding by metabolic
enzymes in development.
Cell cycle and cytoskeleton regulators CycB and EB1 are RBPs.
We confirmed the RNA-binding ability of two newly discovered
RBPs using a reciprocal approach that involves ultraviolet
cross-linking of RNA to proteins, purification of proteins of
interest and detection of bound RNA7,27,28. As targets for
validation we chose cyclin B (CycB) and end-binding protein 1
(EB1), two proteins with important roles in the early embryonic
mitotic divisions—a process that temporally overlaps and is
impacted on by the MZT29,30.
We employed flies expressing transgenic EB1-GFP, endogen-
ously tagged GFP-CycB or free GFP. After ultraviolet crosslinking
of live embryos, each candidate protein was immunoprecipitated
and purified under stringent conditions using the anti-GFP
nanobody31. Upon immunoprecipitation and extensive washing,
we obtained high yields of GFP proteins, as illustrated by the case
of free GFP in Fig. 3a. Following partial digestion, CL RNA was
32P labelled using T4 polynucleotide kinase (PNK), and the
protein–RNA complexes were visualized by immunoblotting.
Immunoprecipitates of free GFP from both CL and noCL
embryos did not contain radioactively labelled proteins in the
expected size range (Fig. 3b). Immunoprecipitates from
ultraviolet-irradiated GFP-CycB and EB1-GFP samples yielded
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discrete radioactive bands after PNK assay at the positions
expected for each fusion protein (Fig. 3c,d), and the intensity of
these bands was stronger in CL than in noCL samples, and the
mass of radioactively labelled complexes depended on RNase A
dose, as expected of bona fide RBPs. Immunoblotting confirmed
the efficient immunoprecipitation of both GFP-CycB and
EB1-GFP, as well as smaller products, presumably proteolytic
fragments (Fig. 3c,d, lower panels). A presumed degradation
product of EB1-GFP ofB45 kDa was radioactively labelled, along
with the full-length protein, in a ultraviolet-dependent, RNAse-
dependent manner, which is indicative of its RNA-binding
activity. Because this fragment is fused to GFP, it should include
the C-terminal APC-binding domain of EB1-GFP32.
Dynamics of the RNA-bound proteome during the MZT. To
evaluate the changes in composition of the RNA-bound proteome
that take place during the MZT, we compared 0–1 h to 4.5–5.5 h
ultraviolet-irradiated embryos (Fig. 4a). Protein profiles of
RNA-bound fractions at the two stages were different, as revealed
by PAGE and silver staining (Fig. 4b). Three independent
biological replicates prepared from embryos collected at these two
time windows were analyzed in parallel by TMT MS3 (see
Methods section) using six different isobaric labels (Fig. 4c).
Unique peptides were assigned to a total of 1,131 proteins, which
included the majority of previously identified RNA interactome
proteins (490 of 523). We calculated protein intensity ratios in
late (4.5–5.5 h) versus early (0–1 h) RNA-bound fractions for all
proteins detected (994) and identified 116 proteins that were
significantly enriched at one of the stages with 10% FDR and 12
with 1% FDR, (Fig. 4d; Supplementary Fig. 3a,b).
To test whether such enrichment in the RNA-bound fraction
merely reflects a change in proteins’ overall abundance during
development, or whether their RNA-binding activity is
modulated, we analyzed whole proteome of 0–1 h and 4.5–5.5 h
embryos, following a similar MS approach (Fig. 4c), and
calculated late/early protein intensity ratios. A total of 1,033
proteins (28% of 3,655 proteins constituting the total proteome)
were significantly enriched at one of the developmental stages:
785 with 10% FDR and 248 with 1% FDR (Fig. 4e; Supplementary
Fig. 3c,d). We plotted the early/late abundance ratio of each
protein in the RNA-associated fraction (ordinate) versus its
early/late abundance ratio in the whole embryo proteome
(abscissa) (Fig. 4f). Three classes of proteins emerged from this
analysis: class 1: proteins whose abundance in the RNA-bound
fraction and in the total proteome remain unaltered (grey dots;
1,015 proteins of which 405 are in the RNA interactome); class 2:
proteins whose change in abundance in the RNA-bound fraction
correlates with the abundance change in the whole proteome
(black dots; 78 proteins, 31 of which are in the interactome); and
class 3: proteins whose abundance in the RNA-bound fraction
changed although their overall abundance in the whole embryo
remains unaltered. This class also includes 6 proteins whose
abundance in the RNA-bound fraction was reduced at the later
stage, but their overall abundance in the embryo increased during
development. Class 3 totalled 38 proteins, 27 of which are in the
RNA interactome. We refer to these class 3 proteins as ‘dynamic
binders.’ (Fig. 4g). Interestingly, classes 2 and 3 were enriched in
previously known RBPs as compared to class 1, which contains
the majority of the novel RBPs (Supplementary Fig. 3e). The
majority of differentially expressed RBPs (50 of 78 class 2
proteins) and 35 of the 38 ‘dynamic binders’ were enriched in the
RNA-bound fraction of early, pre-MZT embryos. Results of our
proteomic analysis are presented in Supplementary Data 4.
Interestingly, the single GO term enriched among the 38
dynamically regulated RBPs compared to all proteins identified in
the RNA-bound fraction is ‘mRNA splicing’ (Fig. 5a). Eight of
these are known splicing factors (Snf, Prp8, X16, Rsf1, ASF/SF2,
Hrb98DE, Neos, PSI), and all but Prp8 bind RNA preferentially
in early embryos, when embryonic development relies on
maternally deposited mRNAs. We tested whether the reduced
RNA binding of ASF/SF2 and PSI in the 4.5–5.5 h sample could
be due to different abundance of their target RNAs at those time
points, and calculated expression change of mRNAs identified as
their presumable targets in an RNAi screen33. The abundance
change of splicing factor target mRNAs between 4.5–5.5 h and 0–
1 h embryos is statistically indistinguishable for all four splicing
factors, and for all genes (Fig. 5b).
To assess whether alternative mRNA splicing, which has
the potential to alter protein structure34, could account for
the modulation of RNA-binding activity of some proteins we
observed in our experiments, we performed whole-transcriptome
sequencing of 0–1 h and 4.5–5.5 h embryos, and analyzed
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(a) Optimization of GFP immunoprecipitation. Protein profiles of total
embryo lysates, IPs of free GFP and unbound fractions are visualized on a
silver stained polyacrylamide gel. Lanes 1–3: serial dilution of total embryo
lysate expressing free GFP; lanes 4–6: serial dilution of unbound fractions
after GFP-IP; lanes 7–10: GFP immunoprecipitates washed with buffers
containing increasing concentrations (none; 0.01%; 0.05%; 0.1%) of SDS.
(b–d) Lysates containing free GFP, EB1-GFP and GFP-CycB were treated
with various concentrations of RNase A. GFP proteins were IPed from noCL
and CL embryos, radioactively labelled, separated on polyacrylamide gels
and blotted on PVDF membranes. Upper panels: autoradiography of
membranes containing IPs of GFP (b), EB1-GFP (c) and GFP-CycB
(d) labelled with g-[32P]-ATP by T4 polynucleotide kinase (see Methods
section, PNK assay). Lower panels: visualization of GFP proteins by
WB with an anti-GFP antibody.
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differential exon usage35. Comparison of transcript expression
levels measured in two biological replicates (Supplementary
Fig. 4a) shows high correlation between replicates. According to
our results, mRNAs coding for RNA interactome proteins were
strongly enriched in alternatively spliced species compared to
all identified mRNAs (Fischer’s exact test for count data:
P value¼ 4.204e 13). Enrichment rates of alternatively spliced
mRNAs among those coding for RBPs and RBP candidates were
similar in the three aforementioned dynamic classes (Fig. 5c).
We performed enrichment analysis of protein features encoded
by alternatively expressed exons in the entire transcriptomes of
early and late stage embryos. Several domains were enriched in
sequences encoded by all alternative exons, including two known
RBDs—KH-1 and RRM-1 (Fig. 5d). In addition, some RBPs are
encoded by alternatively spliced mRNAs, and alternative exons
contain RBDs. However, we could not find direct evidence for
alternative inclusion of RBDs by mass spectrometry, likely due to
insufficient depth of the proteomic data. In accordance with
previous findings36, disordered regions were enriched in exons
that were both upregulated and downregulated at the early stage.
Interestingly, disordered regions were enriched stronger in the
exons that were preferentially used at the early stage
(P value¼ 5.56e 48) than in the exons used at the late stage
(P value¼ 3.23e 02) (Supplementary Fig. 4b,c). When
compared to exons preferentially used at the late stage,
alternative exons preferentially used in early stage mRNAs
are enriched for 27 different domains, including some
well-characterized RBDs (Supplementary Fig. 4c).
Discussion
This resource presents the first, to our knowledge, comprehensive
list of RBPs in D. melanogaster at different developmental stages
obtained in an unbiased proteome-wide experiment. Selection of
the RNA-bound protein fraction was achieved through cross-
linking of RBPs to RNA by ultraviolet light and specific
precipitation of poly(A)þ RNA on oligo(dT) magnetic beads
under stringent conditions. We improved the RNA capture
procedure, that was initially optimized for cell lines12, by
increasing lysis temperature to 60 C and using higher DTT
concentration (12.5mM). This step allowed the complete removal
of tubulin, which is presumably not an RBP, and did not lead to
any detectable RNA damage.
Analysis of captured samples by the recently developed TMT
MS3 method17 identified 523 high-confidence RBPs in
Drosophila, despite the fact that enrichment of some proteins
could not be quantified due to missing intensity values in the
control noCL sample. Although this technical issue made data
analysis challenging, it signified that our efforts in reducing
protein background resulted in generation of extremely high
quality RBP specimens, where background signal in the negative
control was close to zero for most of the proteins quantified in the
ultraviolet-irradiated samples. Our data show that TMT MS3
allows efficient reduction of experimental noise, but challenge the
current data analysis pipelines where the existence of an intensity
ratio between the two conditions is required to quantify a
protein37.
We generated the most comprehensive list of high-confidence
Drosophila RBPs so far by applying the optimized RNA
interactome capture method to embryos at two distinct
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Figure 4 | Study of RNA interactome dynamics during the maternal-to-
zygotic transition. (a) Schematic representation of the MZT. Shaded areas
show the time frames considered in our study. (b) Proteins captured from
three biological replicates of CL early (0–1 h) and late (4.5–5.5 h) embryos
were partially digested, labelled by six different TMT labels and analyzed by
MS. (c) Protein profiles of total lysates and RNA-bound fractions recovered
from early and late embryos, noCL and CL. (d,e) Ratios of protein
abundance late/early in two of the three biological replicates.
(d) RNA-bound fractions, (e) total lysates. Red dots: proteins whose
abundance significantly changes at FDR 1%; yellow dots: proteins whose
abundance changes at FDR 10%. Supplementary Fig. 3a,c includes the same
plots, with P values and Pearson correlation values indicated. (f) Scatter
plot showing change of average protein abundance early/late in RNA-bound
fractions (ordinate) and total protein lysates (abscissa). Grey dots: proteins
whose abundance does not significantly change neither in the RNA-bound
fraction, nor in the total embryo lysate. Black dots: proteins whose
abundance change in the RNA-bound fractions follows the change in
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their RNA-binding capacity (‘dynamic binders’). (g) Numbers of proteins in
each of the dynamic classes defined in (f). Red: numbers of proteins
belonging to the RNA interactome. Blue: numbers of proteins not belonging
to the interactome.
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developmental stages—before and after the MZT. Our analysis
confirms RNA-binding ability of hundreds of previously known
RBPs and provides new links between RNA metabolism and
development, including new evidence for RBP involvement in
regulation of cell differentiation38. Some well-known RBPs
expressed in the early embryo were not captured in our
experiments, possibly because of association with deadenylated
mRNAs present at early stages39, or the limited ability of the
254 nm ultraviolet light to penetrate the optically dense embryo,
and therefore, activate nucleobases of RNAs located in its deepest
layers14. Our results provide first insight into the molecular
function of many essential proteins, including those involved in
neurodevelopment, and call for further mechanistic studies.
Our comparison of the Drosophila interactome with data
available for four other species reveals that proteins that are
conserved and appear in all interactomes are predominantly
previously known RBPs involved in core processes of RNA
metabolism, such as translation and processing, whereas species-
specific proteins are enriched for novel RBPs. This also highlights
the utility of an experimental technique such as interactome
capture for discovery of novel, species-specific RBPs.
In light of evidence indicating that regulation of metabolism
might be tightly bound to the MZT in Drosophila26, and previous
reports of RNA binding by metabolic enzymes in other
organisms8,10,11, the discovery of such enzymes in Drosophila
is particularly interesting. It was previously shown that 37
mRNAs encoding metabolic enzymes are bound and possibly
downregulated by a key MZT driver, Smaug26. RNA binding by
metabolic enzymes indicates that an additional post-translational
mechanism might regulate their activity. The number of
metabolic enzymes capable of binding RNA is lower in
Drosophila than in other organisms for which RNA
interactomes are available. Why this might be, as well as the
roles of metabolic enzymes in RNA metabolism and regulation,
should be clarified by future studies.
We confirmed the ability of two newly discovered RBPs, CycB
and EB1, to bind RNA directly by a reciprocal approach that
involves precipitation of an individual protein and detection
of the bound RNA by radioactive labelling. In addition, based on
the labelling patterns of presumable degradation products of
EB1-GFP, we propose that its APC binding domain harbours
RNA-binding activity, not excluding, however, that the
N-terminal microtubule-binding domain of EB1 may also
contribute to RNA binding. In contrast, only the full-length
version of GFP-CycB was radioactively labelled, suggesting that
either the full-length or the C-terminal fragment of CycB
mediates RNA binding.
We propose that RNA binding might have a role in CycB
regulation or targeting: for example, localized RNAs might tether
CycB to the loci where its activity is required, such as
centrosomes40. The RNA-binding ability of EB1 might indicate
a role in microtubule dependent transport of mRNAs, as was
recently proposed for APC, another microtubule end-binding
protein also shown to bind RNA41. Further experiments will shed
light on the biological importance of the RNA-binding activity of
CycB and EB1.
Analysis of the RNA interactomes of pre- and post-MZT
Drosophila embryos provided in this study reveals, expectedly,
high dynamicity of the RNA-bound fraction during the MZT and
confirms deeper involvement of RBPs in the early, pre-MZT
embryo that is transcriptionally inactive. Comparison of protein
abundance changes in the RNA-bound fraction and in the total
proteome allowed their separation into three dynamic classes,
which indicates that various mechanisms might regulate RNA
binding, including active regulation of an RBP’s affinity for RNA
and isoform exchange. Possible active regulation mechanisms
include, but are not limited to allosteric regulation by trans-acting
factors such as proteins, RNAs or small molecules, competitive
binding of trans-acting factors at the RNA-binding site and
post-translational modifications. Some RBPs might also appear to
bind RNA more efficiently at one of the stages if the mRNAs that
they bind have undergone a change in polyadenylation status.
Observed dynamic behaviours of some of the known RBPs such
as splicing factors indicate that they may have other functions in
addition to previously characterized ones. The fact that these
splicing factors preferentially bind RNA in the early, pre-MZT
b
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Figure 5 | Possible explanations for dynamic behaviour of some of the
RBPs during the MZT. (a) Ten most enriched GO terms related to
biological process among the class 3 RBPs and RBP candidates (‘dynamic
binders’). (b) Log2 change in expression levels (RPKM) of putative
transcript targets of four splicing factors and all genes. Splicing factors’
targets are identified as transcripts whose abundance is significantly
affected (|z-score|42) upon depletion of a splicing factor33. Comparison of
changes in expression of all genes and splicing factor targets using the
Student t-test resulted in the following P values: ASF/SF2–0.6698;
Hrp48–0.1532; PSI—0.5239; B52–0.1847. (c) Enrichment of alternatively
spliced mRNAs in the whole RNA interactome and in the three dynamic
classes. Odds ratios are presented. (d) Pfam domains enriched among
exons that are differentially used between 0–1 h and 4.5–5.5 h embryos
Known RBDs are indicated in red.
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embryo is surprising for two reasons: first, transcription, and
accordingly, pre-mRNA processing is generally low in the rapidly
dividing nuclei of embryos at the early, syncytial stage42. Second,
the nucleus–cytoplasm ratio in early embryos is low, hence
increased abundance of the splicing factors in the early stage
indicates that they are bound to cytoplasmic RNAs. This could
reflect that the splicing factors are either stockpiled in an inactive,
RNA-bound state until the onset of transcription, or they perform
so far unexplored cytoplasmic roles in the early embryo. These
findings open new avenues for research and will help better
understand the universal process of the MZT.
By analyzing protein features encoded by exons that are
differentially expressed during the MZT we determined that
alternative splicing indeed has the potential to affect the
architecture of an RBP and therefore can impact on the
biochemical properties of the protein. The fact that inclusion of
some RBDs occurs preferentially in the early, transcriptionally
quiescent stage aligns well with the special importance of RBPs in
the post-transcriptional control of maternal mRNAs.
Differential exon expression analysis also revealed that
disordered regions are alternatively spliced at both stages, in
accordance with previous reports36. The stronger enrichment of
disordered regions in alternative exons upregulated in the early
embryo correlates with the broader involvement of RBPs at this
stage. Such regions may have various roles in the early embryo: in
addition to their presumable binding and regulation of RNA8,43,
they may be involved in assembly of higher order protein or
protein–RNA complexes, in processes similar to phase transition
and hydrogel formation44,45, or the binding of proteins to the
C-terminal domain of RNA polymerase II (ref. 9) (reviewed by
Ja¨rvelin et al.46). Large molecular complexes held together by
interactions of disordered protein domains might be components
of even larger units, and have roles in organization of the early
embryo syncytial cytoplasm that is not yet subdivided by
membranes to form cells. Further in depth mechanistic studies
of disordered regions will advance our understanding of their
roles in RNA regulation and other cellular processes.
Methods
Fly stocks. Flies were maintained according to standard procedures at 25 C.
D. melanogaster Oregon-R flies were used to obtain embryos for RNA interactome
capture (Bloomington Stock 5). RNA-binding activity of CycB and EB1 was
validated using the endogenously tagged w1118; cycB FlyTrap line (Bloomington
Stock 51568, (ref. 47)), and flies expressing transgenic Eb1-gfp under control of the
UAS promoter48 driven by nos-gal4::vp16 (ref. 49), respectively.
Embryo collection, cross-linking, oligo(dT) pull-down. Zero-to-one hour-old
embryos collected from ten population cages each containing B 10,000 flies were
either processed immediately (0–1 h, early embryos) or incubated for 4.5 h and
then processed (4.5–5.5 h, late embryos). After collection on a 0.18mm mesh sieve,
embryos were rinsed with distilled water, weighed and the sample was split into
two. One half (noCL, control sample) was homogenized in lysis buffer (20mM
Tris–HCl pH 7.5, 500mM LiCl, 1mM ethylenediaminetetraacetate—EDTA,
5 g l 1 Li-dodecylsulphate, 12.5mM dithiothreitol—DTT). The other half was
irradiated with 1.0 J cm 2 254 nm ultraviolet light (Stratalinker 1800) on ice under
a layer of ice-cold phosphate buffered saline supplemented with 0.1% Tween-20,
collected on a sieve, then homogenized in lysis buffer. After lysis embryo extracts
were cleared by centrifugation at 15,000g for 30min, diluted to total protein
concentration 0.1mgml 1, incubated at 60 C for 150 and cooled to room
temperature.
Poly(A)þ RNA was captured according to the protocol of ref. 12. A total of
2.5ml suspension of magnetic oligo(dT) beads were used per 100ml of embryo
extract. Oligo(dT) beads were incubated with the extracts for 1 h at room
temperature, then washed 1 with lysis buffer, 2 with buffer containing 20mM
Tris–HCl pH 7.5, 500mM LiCl, 1mM EDTA, 1 g l 1 Li-dodecylsulphate, 1mM
DTT, 2 with buffer containing 20mM Tris–HCl pH 7.5, 500mM LiCl, 1mM
EDTA, 1mM DTT, 2 with buffer containing 20mM Tris–HCl pH 7.5, 200mM
LiCl, 1mM DTT. RNA-protein complexes were eluted by vigorous shaking at 55 C
in elution buffer (20mM Tris–HCl, 1mM EDTA).
To obtain optimal yields of poly(A)þ RNA, each lysate was put through the
RNA interactome capture procedure four times. Eluates from subsequent rounds of
RNA interactome capture were pooled and concentrated using Amicon filter units
with a molecular weight cut-off of 3,000Da.
Staging of embryos. An aliquot of embryos used for RNA interactome
capture was dechorionated by bleach treatment (30 s incubation in 5% NaClO),
rinsed with distilled water and fixed in a 1:1 mixture of heptane and
methanol. After gradual rehydration, embryos were stained with 0.1 mgml 1
40,6-diamidino-2-phenylindole (DAPI) and visualized on a confocal fluorescent
microscope.
Quality control of captured RNA complexes. To control the quality of the
captured RNA, an aliquot of each eluate was treated with protease K and
subsequently purified as in ref. 12. A total of 100 ng of each RNA sample was
analyzed on an Agilent Bioanalyzer 2100 according to the manufacturer’s
recommendations.
For quantification of 18S rRNA and gapdh1 and ts mRNAs, we performed
reverse transcription followed by RT-qPCR. RT was performed using the
SuperScript III first-strand synthesis system (Thermo Fischer Scientific), equal
amounts of total and oligo(dT) captured RNA were used. Dilutions of first-strand
DNA libraries prepared from total noCL RNA were used as standards.
Amplification was performed in the presence of 1mM of each oligonucleotide and
1 SYBR Green RCR Master Mix (Applied Biosystems). Relative amounts of
targets were calculated using StepOne software. Sequences of oligonucleotides
used for quantification of 18S rRNA were taken from ref. 50. Sequences of
oligonucleotides used for quantification of gapdh1 and ts mRNAs were designed
with Primer3 software51,52. Sequences of oligonucleotides used in the study are
presented in the Supplementary Table 1.
Analysis of captured proteins. Eluates were supplemented with RNase buffer to a
final concentration 20mM Tris–HCl pH 7.5, 150mM NaCl and 200Uml 1 of
RNases A and T1. After 30min incubation at 37 C an aliquot of proteins was
supplemented with LiDS loading buffer (Thermo Fischer Scientific) containing
20mM DTT, separated on 4–12% polyacrylamide gels (NuPage, Thermo Fischer
Scientific) and either stained with silver using Pierce Silver Stain Kit (Thermo
Fischer Scientific) or electrophoretically transferred onto polyvinylidene fluoride
(PVDF) membranes.
PVDF membranes were blocked in phosphate buffered saline supplemented
with 0.1% Tween-20 (PBST) and containing 100 g L 1 milk powder. Membranes
were then hybridized with antibodies diluted in PBST-milk that are listed in
Supplementary Table 2. Membranes were washed with PBST, hybridized with
secondary antibodies conjugated with horseradish peroxidase (GE Healthcare) and
developed using Western Lightning Plus ECL kit (PerkinElmer). Full-size images of
the most important immunoblots are available in the Supplementary Fig. 1.
MS, protein identification and quantification. Captured proteins were digested
with Lys-C and labelled with 6plex TMT as previously described53, fractionated by
high pH reverse phase chromatography and analyzed on LTQ-Orbitrap Velos Pro
mass spectrometer (Thermo Scientific). MS analysis and identification and
quantification of proteins is described in detail in Supplementary Note 2.
Validation of RNA-binding ability by PNK assay. Zero-to-two hour-old embryos
expressing GFP, GFP-CycB or EB1-GFP and w1118 embryos were collected and
irradiated with 1 J cm 2 ultraviolet light (254 nm) and lysed in 10 RIPA buffer
(20mM Tris–HCl pH 7.5, 150mM KCl, 0.5mM EDTA, 1% Triton-X100,
1% deoxycholate and 0.1% sodium dodecylsulphate—SDS, 5mM DTT, 5 Roche
protease inhibitor cocktail) and cleared by 10min centrifugation at 15,000g. Lysates
containing GFP were diluted with w1118 lysates to reduce GFP concentration to
levels comparable with those of GFP-CycB and EB1-GFP. Lysates were diluted with
RIPA buffer to 10mgml 1 total protein, then diluted 1:10 with low salt buffer
(20mM Tris–HCl pH 7.5, 150mM KCl, 0.5mM EDTA) to reduce the con-
centration of detergents. A total of 10 ml of suspension of magnetic beads coated
with Lama alpaca anti-GFP antibody (Chromotek GFP-Trap_M) were added to
1ml of each lysate and incubated at 4 C for 2 h. Beads were washed six times with
1ml high salt buffer (20mM Tris–HCl pH 7.5, 500mM KCl, 1mM EDTA, 0.1%
SDS, 0.5mM DTT, 1 Roche protease inhibitor cocktail). Washes were performed
at room temperature to avoid SDS precipitation. Beads were then washed twice
with 1 T4 PNK buffer B (Thermo Fischer Scientific) and incubated for 15min in
10 ul of reaction mix containing 1 T4 PNK buffer B, 2 ml T4 PNK and 1 mCi
g-32P-adenosyntriphosphate (g-ATP) (Hartmann Analytic). Beads were then
separated from the reaction mix and washed 5 times with low salt buffer
supplemented with 0.1% Triton-X100. Labelled complexes of GFP proteins and
RNA were eluted by incubation in 1 LiDS buffer (Thermo Fischer Scientific),
separated on polyacrylamide gels and transferred to PVDF membranes as
described above. Autoradiography was recorded using phosphor screens and GE
Typhoon 7000 scanner, and GFP proteins were detected as described above.
Transcriptome analysis. To determine the total transcriptome, poly(A)þ RNA
from 0–1 h and 4.5–5.5 h-old embryos was purified as described above, treated
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by Turbo DNase I (Thermo Fischer Scientific) according to manufacturer’s
instructions and purified by phenol–chloroform extraction and ethanol
precipitation. cDNA libraries were prepared form the resulting samples using a
SENSE mRNA-Seq Library Prep Kit V2 (Lexogen) and analyzed by single-end 50
sequencing on an Illumina HiSeq2000. Reads were aligned to the Drosophila
reference genome version R6.07 using STAR. Differential exon usage was called
using the R/Bioconductor package DEXSeq.
Data availability. The MS proteomics data that support the findings of this study
have been deposited in the ProteomeXchange Consortium via the PRIDE partner
repository54 with the dataset identifier PXD003882. All relevant data and computer
code that support the findings of this study are available from the authors upon
request.
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